What Technical Analysis say About bluebird bio, Inc. (NASDAQ:BLUE)?


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of bluebird bio, Inc. (NASDAQ:BLUE) for the period of 9-Day stands at 90.24% while the stochastic %D for the same period stands at 69.17%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of bluebird bio, Inc. (NASDAQ:BLUE) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for bluebird bio, Inc. (NASDAQ:BLUE) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently bluebird bio, Inc. (NASDAQ:BLUE)’s 20-Day Bollinger Band indicates “Buy”.

About Company

Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio, Inc. is headquartered in Cambridge, Massachusetts.

Previous Day Activity Analysis

On the last trading day, bluebird bio, Inc. (NASDAQ:BLUE) opened the session at $134.1 and after going up 8.81% closed at $143.3. The stock gained 9.2 points in the last trade.

bluebird bio, Inc. (NASDAQ:BLUE)’s stock fluctuated in the range of $132.45 and $143.40 during the previous active session. bluebird bio, Inc. (NASDAQ:BLUE) traded with the volume of 1.14 Million with average volume of 813.59 Million. The stock has MEDIUM volatility on the last trading session.

Currently the Beta for the company remains at 2.03 while ATR (Average True Range) and RSI (Relative Strength Index) are at 6.4 and 65.98 respectively.

Currently the Insider Ownership of the shares of bluebird bio, Inc. (NASDAQ:BLUE) is at 0.9% and the shares outstanding are 45.07 Million.

Important Ratio Analysis

Some important ratios to consider here for bluebird bio, Inc. (NASDAQ:BLUE) are discussed below:

The Price to Sale P/S and Price to Book P/B shows the value of 241.89 and 4.9 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 5.9 and 0 correspondingly.

The Quick Ratio of bluebird bio, Inc. (NASDAQ:BLUE) stands at 14.4 while the Current Ratio depicts the value of 14.4.

Return on Assets ROA of bluebird bio, Inc. (NASDAQ:BLUE) is at -25.2% whereas, Return on Equity ROE and Return of Investment ROI of bluebird bio, Inc. (NASDAQ:BLUE) stand at -32.2% and -27% respectively.

Stock Performance Analysis

The stock performance of bluebird bio, Inc. (NASDAQ:BLUE) on the basis of 5 day trade show the jump of 8.97% whereas, the monthly performance of the stock shows increase of 8.89%.

The quarterly performance of the stock remained in green zone with the value of 52.69% while six month performance of the shares of bluebird bio, Inc. (NASDAQ:BLUE) remained bullish with the count of 71.41%.

The yearly and YTD performance of bluebird bio, Inc. (NASDAQ:BLUE) remained up at 153.31% and 132.25% respectively.